Willingness to Participate in a Personalized Health Cohort - Insights from the Swiss Health Study Pilot Phase

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2024 Aug 7

PMID 39112992

Authors

Nolwenn Buhler

Annika Frahsa

Nathalia Gonzalez Jaramillo

Rejane Morand Bourqui

Semira Gonseth Nussle

Claire Zuppinger

Murielle Bochud

Natalie von Goetz

Affiliations

Soon will be listed here.

Abstract

Background: This paper explores the feasibility of establishing a large-scale population-based cohort and biobank in Switzerland by assessing potential participants' needs, expectations, and concerns about such an infrastructure providing information on health, lifestyle, and exposure trajectories, the development of disease, and risk factors over time.

Methods: We utilized a scenario-based questionnaire in the Swiss Health Study pilot phase (2020-2021), involving 1349 adults aged 20-69 from the cantons Vaud and Bern. We conducted descriptive statistics supported by R and qualitative content analysis of n = 374 open responses related to attitudes towards research.

Results: We highlight the benefits and challenges of the scenario-based approach, discuss the sample represented in the pilot phase, and present implications for building a full cohort. We also report on participants' attitudes towards and previous experience with health research. We analyze references regarding informed consent and feedback, attitudes towards the Swiss Health Study, and recommendations on improving its scope, design, and instruments. Results indicate a high interest (90%) in participating in a national health study, with 85% of a random population sample willing to join a long-term cohort. Only 43% were familiar with biobanks, and 44% preferred general consent. Trust was high for Swiss-based public research but lower for researchers from other countries or private sector. Over 95% expressed willingness to complete online questionnaires, undergo physical examination, and donate biosamples. Almost all participants wanted to know the outcomes of the medical tests (99.5%) and the exposure to environmental stressors (95%) from their study center visit. Preferred tools for monitoring sleep, physical activity, and diet were known smartphone apps with automatic data management.

Conclusion: Overall, the study reveals a positive attitude towards personalized health research, with a strong willingness to share data and samples. Key insights focus the meaning of informed consent for participation, the relevance of sampling and representativeness, as well as the significance and challenges of personalized feedback, especially regarding environmental health concerns. Findings emphasize participants' supportive yet reflexive stances, underscoring the importance of aligning research values with individual values in personalized health research. These insights contribute valuable considerations for refining the scope, design, and instruments of future cohort studies.

References

Buhler N, Frahsa A, Bourqui R, Von Gotz N, Bochud M, Panese F . Between data providers and concerned citizens: Exploring participation in precision public health in Switzerland. Public Underst Sci. 2023; 33(1):105-120. PMC: 10756011. DOI: 10.1177/09636625231183265. View

Wetterberg H, Ryden L, Ahlner F, Falk Erhag H, Gudmundsson P, Guo X . Representativeness in population-based studies of older adults: five waves of cross-sectional examinations in the Gothenburg H70 Birth Cohort Study. BMJ Open. 2022; 12(12):e068165. PMC: 9764666. DOI: 10.1136/bmjopen-2022-068165. View

Spoerri A, Zwahlen M, Egger M, Bopp M . The Swiss National Cohort: a unique database for national and international researchers. Int J Public Health. 2010; 55(4):239-42. DOI: 10.1007/s00038-010-0160-5. View

Khoury M, Iademarco M, Riley W . Precision Public Health for the Era of Precision Medicine. Am J Prev Med. 2015; 50(3):398-401. PMC: 4915347. DOI: 10.1016/j.amepre.2015.08.031. View

Brall C, Berlin C, Zwahlen M, Vayena E, Egger M, Ormond K . Public preferences towards data management and governance in Swiss biobanks: results from a nationwide survey. BMJ Open. 2022; 12(8):e060844. PMC: 9422864. DOI: 10.1136/bmjopen-2022-060844. View

Tupasela A, Snell K, Canada J . Constructing populations in biobanking. Life Sci Soc Policy. 2015; 11:5. PMC: 4508277. DOI: 10.1186/s40504-015-0024-0. View

Snell K, Tarkkala H . Questioning the rhetoric of a 'willing population' in Finnish biobanking. Life Sci Soc Policy. 2019; 15(1):4. PMC: 6535850. DOI: 10.1186/s40504-019-0094-5. View

Brall C, Berlin C, Zwahlen M, Ormond K, Egger M, Vayena E . Public willingness to participate in personalized health research and biobanking: A large-scale Swiss survey. PLoS One. 2021; 16(4):e0249141. PMC: 8016315. DOI: 10.1371/journal.pone.0249141. View

Bopp M, Spoerri A, Zwahlen M, Gutzwiller F, Paccaud F, Braun-Fahrlander C . Cohort Profile: the Swiss National Cohort--a longitudinal study of 6.8 million people. Int J Epidemiol. 2008; 38(2):379-84. DOI: 10.1093/ije/dyn042. View

10.

Probst-Hensch N, Bochud M, Chiolero A, Crivelli L, Dratva J, Flahault A . Swiss Cohort & Biobank - The White Paper. Public Health Rev. 2023; 43:1605660. PMC: 9817110. DOI: 10.3389/phrs.2022.1605660. View

11.

Rochat J, Gaudet-Blavignac C, Del Zotto M, Ruiz Garretas V, Foufi V, Issom D . Citizens' Participation in Health and Scientific Research in Switzerland. Stud Health Technol Inform. 2020; 270:1098-1102. DOI: 10.3233/SHTI200332. View

12.

Barazzetti G, Bosisio F . A Value-Oriented Framework for Precision Medicine. Am J Bioeth. 2021; 21(4):88-90. DOI: 10.1080/15265161.2021.1891338. View

13.

Mahlmann L, Schee Gen Halfmann S, von Wyl A, Brand A . Attitudes towards Personal Genomics and Sharing of Genetic Data among Older Swiss Adults: A Qualitative Study. Public Health Genomics. 2018; 20(5):293-306. DOI: 10.1159/000486588. View

14.

Coppola L, Cianflone A, Grimaldi A, Incoronato M, Bevilacqua P, Messina F . Biobanking in health care: evolution and future directions. J Transl Med. 2019; 17(1):172. PMC: 6532145. DOI: 10.1186/s12967-019-1922-3. View

15.

Bochud M, Currat C, Chapatte L, Roth C, Mooser V . High participation rate among 25 721 patients with broad age range in a hospital-based research project involving whole-genome sequencing - the Lausanne Institutional Biobank. Swiss Med Wkly. 2017; 147:w14528. DOI: 10.4414/smw.2017.14528. View

16.

Vaithinathan A, Asokan V . Public health and precision medicine share a goal. J Evid Based Med. 2017; 10(2):76-80. DOI: 10.1111/jebm.12239. View

17.

Raz A, Timmermans S, Eyal G, Brothers K, Minari J . Challenges for precision public health communication in the era of genomic medicine. Genet Med. 2022; 24(9):1814-1820. DOI: 10.1016/j.gim.2022.05.010. View

18.

Preisig M, Waeber G, Vollenweider P, Bovet P, Rothen S, Vandeleur C . The PsyCoLaus study: methodology and characteristics of the sample of a population-based survey on psychiatric disorders and their association with genetic and cardiovascular risk factors. BMC Psychiatry. 2009; 9:9. PMC: 2667506. DOI: 10.1186/1471-244X-9-9. View

19.

Enzenbach C, Wicklein B, Wirkner K, Loeffler M . Evaluating selection bias in a population-based cohort study with low baseline participation: the LIFE-Adult-Study. BMC Med Res Methodol. 2019; 19(1):135. PMC: 6604357. DOI: 10.1186/s12874-019-0779-8. View

20.

Kerasidou A . Trust me, I'm a researcher!: The role of trust in biomedical research. Med Health Care Philos. 2016; 20(1):43-50. PMC: 5318478. DOI: 10.1007/s11019-016-9721-6. View